Label Changes for:
Ethrane (enflurane) liquid for inhalation
Changes have been made to the ADVERSE REACTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – January 2010
- Cardiac Disorders: Cardiac arrest
- Hepatobiliary Disorders: Hepatic necrosis, Hepatic failure